Erlotinib and disease progression 
Erlotinib and disease progression Patient Reports February 11, 2012
Erlotinib Side Effects Report #5455928-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 30, 2007. Female patient was diagnosed with pulmonary mass and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, clavicle fracture, disease progression, fall
, fatigue, pain . Erlotinib dosage: 150 MG (QD, ORAL. During the same period patient was treated with TOPOTECAN, ARANESP, LEVAQUIN, POTASSIUM CHLORIDE, NEULASTA. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5186693-2
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 27, 2006. Male patient, 69 years of age, was diagnosed with prostate cancer
and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abasia, cough, dehydration, delusion, difficult to wean from ventilator, disease progression, dizziness , dyskinesia, dysstasia. Erlotinib dosage: 150 MG QD, ORAL. Patient was hospitalized. Patient died on 09/23/2006.Erlotinib Side Effects Report #5196227-4
Erlotinib side effect was reported by a Physician from GERMANY on Dec 07, 2006. Female patient, 72 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disease progression, dyspnoea, epistaxis, pancreatic carcinoma metastatic, pleural effusion, pneumothorax. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with ASPIRIN, NEXIUM, SIMVAHEXAL, GEMCITABINE, XANEF, UNAT, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5517710-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Oct 26, 2007. Female patient, 72 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood sodium decreased, dehydration, disease progression, lymphocyte count decreased, thrombocytopenia. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, COLACE, COMPAZINE, DILAUDID, FLUCONAZOLE, GLYBURIDE, MIRALAX. Patient recovered.
Erlotinib Side Effects Report #5125145-2
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Sept 21, 2006. Male patient, 70 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: back pain
, disease progression, fall , hemiparesis, muscular weakness. Erlotinib dosage: 50 MG (QD), ORAL. During the same period patient was treated with GEMCITABINE, DOCUSATE, METFORMIN, ASPIRIN, DEXAMETHASONE, OMEPRAZOLE, DILTIAZEM. Patient was hospitalized. Patient died on 08/27/2006.Erlotinib Side Effects Report #6121207-1
Erlotinib side effect was reported by a Physician from ITALY on Feb 27, 2009. Male patient, 66 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, disease progression, interstitial lung disease, lung disorder, lymphangitis, pneumocystis jiroveci infection, pneumonia
. Erlotinib dosage: (100 MG, QD), ORAL. Patient died.Erlotinib Side Effects Report #5481996-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 20, 2007. Male patient, 63 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bile duct obstruction, bile duct stenosis, blood glucose decreased, cholangitis, confusional state, disease progression, pneumonia aspiration, respiratory distress. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, COLACE, ZOFRAN, COMPAZINE, ATENOLOL, INSULIN NPH, PROPAFENONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5498435-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 08, 2007. Male patient, 63 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bile duct obstruction, blood glucose decreased, cholangitis, confusional state, disease progression, malignant hepatobiliary neoplasm, pneumonia aspiration, prothrombin time prolonged. Erlotinib dosage: 100MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, COLACE, ZOFRAN, COMPAZINE, ATENOL, INSULIN NPH, PROPAFENONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5417958-4
Erlotinib side effect was reported by a Physician from UNITED STATES on July 31, 2007. Male patient, 52 years of age, weighting 172.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, pulmonary embolism
. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, ATIVAN, CELEXA, COLACE, MIRALAX, MLD SOLUTION. Patient recovered.Erlotinib Side Effects Report #5243831-0
Erlotinib side effect was reported by a Health Professional from SWEDEN on Feb 05, 2007. Male patient, 51 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardiac arrest
, disease progression. Erlotinib dosage: 100 MG (QD); ORAL. During the same period patient was treated with GEMCITABINE, NOVOMIX, CIPROFLOXACIN, CITODON, MORPHINE SULPHATE, CAPECITABINE, OXALIPLATIN. Patient died on 12/24/2006.Erlotinib Side Effects Report #5491422-9
Erlotinib side effect was reported by a Physician from JAPAN on Oct 03, 2007. Male patient, 71 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, ascites, atelectasis, blood pressure decreased, cardiac disorder, cardiac failure, cholangitis, disease progression, disseminated intravascular coagulation. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with GEMCITABINE, FAMOTIDINE, URSODIOL, MOSAPRIDE CITRATE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5736919-9
Erlotinib side effect was reported by a Physician from KOREA, REPUBLIC OF on Apr 25, 2008. Male patient, 47 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cerebral infarction, disease progression, embolism, headache
, loss of consciousness. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with CAPECITABINE, GEMCITABINE. Patient died on 04/17/2008.Erlotinib Side Effects Report #5766198-8
Erlotinib side effect was reported by a Physician from KOREA, REPUBLIC OF on May 19, 2008. Male patient, 47 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cerebral infarction, disease progression, embolism, headache
, loss of consciousness. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with CAPECITABINE, GEMCITABINE. Patient died on 04/17/2008.Erlotinib Side Effects Report #6021938-8
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 09, 2008. Female patient, 55 years of age, weighting 192.9 lb, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, intestinal obstruction. Erlotinib dosage: 150 MG, DAYS, 1-28, ORAL. During the same period patient was treated with VIDAZA, VICODIN, MAGNESIUM OXIDE, RANITIDINE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5868599-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Aug 15, 2008. Female patient was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, intestinal ischaemia, intestinal perforation, small intestinal obstruction. Erlotinib dosage: (150 MG, QD) ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5782680-1
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2008. Male patient, weighting 92.59 lb, was diagnosed with oesophageal adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridial infection, colitis, disease progression, lobar pneumonia, vena cava thrombosis. Erlotinib dosage: 150 MG, QD, PO. During the same period patient was treated with BEVACIZUMAB, PROGRAF, MYFORTIC, PREVACID, LIPITOR, PREDNISONE, METOPROLOL SUCCINATE, ASPIRIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5783016-2
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2008. Male patient, weighting 138.9 lb, was diagnosed with oesophageal adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, disease progression, dysphagia, fatigue, nausea
, odynophagia, oral intake reduced, weight decreased. Erlotinib dosage: 150 MG, QD, PO. During the same period patient was treated with BEVACIZUMAB, PROGRAF, MYFORTIC, PREVACID, LIPITOR, PREDNISONE, METOPROLOL SUCCINATE, ASPIRIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5262366-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 09, 2007. Male patient, weighting 169.0 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atelectasis, disease progression, obstructive airways disorder, pleural effusion, pneumonia
. Erlotinib dosage: 175MG DAILY PO. During the same period patient was treated with NORVASC, NEXIUM, NOVOLOG, LANTUS, PRANDIN, VYTORIN, AMBIEN, OXYCODONE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6121320-9
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Feb 26, 2009. Male patient, 82 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, pneumonia aspiration, sputum discoloured. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with DEXAMETHASONE, ORAMORPH, LISINOPRIL, SIMVASTATIN, GLICLAZIDE. Patient was hospitalized. Patient died on 07/08/2008.
Erlotinib Side Effects Report #5744908-3
Erlotinib side effect was reported by a Health Professional from JAPAN on May 02, 2008. Female patient, 78 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: delirium, dementia
, disease progression, disorientation, memory impairment, rash . Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with WARFARIN POTASSIUM, ALFACALCIDOL, RISEDRONIC ACID, ASPARA, LACTOBACILLUS BIFIDUS, OMEPRAL, ETODOLAC, OXYCONTIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5268852-3
Erlotinib side effect was reported by a Physician from ITALY on Feb 23, 2007. Male patient, 76 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with FENTANYL, LACTULOSE, PAROXETINE, PREDNISONE, ESOMEPRAZOLE, PHENOBARBITAL. Patient died.
Erlotinib Side Effects Report #5529998-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 12, 2007. Female patient, 75 years of age, weighting 151.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain lower, diarrhoea, differential white blood cell count abnormal, disease progression, diverticulum intestinal, gallbladder disorder, haematocrit decreased, haemoglobin decreased, lymphadenopathy mediastinal. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE, NORVASC, BENAZEPRIL, LEXAPRO, DETROL, CLIRINEX, HYDROCHLOROTHIAZIDE, IRON POLYSACCHARIDE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5250757-5
Erlotinib side effect was reported by a Physician from GERMANY on Feb 09, 2007. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, chest pain
, constipation , dehydration, disease progression, fall , infection . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with OXYCODONE, MOVICOL, NEXIUM, NOVALGIN, INSULIN, METOCLOPRAMID, SPIRONOLACTONE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5634112-1
Erlotinib side effect was reported by a Physician from GERMANY on Feb 14, 2008. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, chest pain
, constipation , dehydration, disease progression, fall , infection , nausea . Erlotinib dosage: 150 MG (150 MG, QD), ORAL. During the same period patient was treated with OXYCODONE, MOVICOL, NEXIUM, NOVALGIN, INSULIN, METOCLOPRAMID, SPIRONOLACTONE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5339603-9
Erlotinib side effect was reported by a Physician from UNITED STATES on May 10, 2007. Male patient, 73 years of age, weighting 191.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: aortic arteriosclerosis, asthenia, body temperature decreased, cerebral atrophy, chest x-ray abnormal, clostridium difficile colitis, diastolic dysfunction, disease progression, emphysema. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, MEGACE, DUONEB, PERCOCET, PROTONIX. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5463845-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Sept 04, 2007. Male patient, 73 years of age, weighting 191.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: aortic arteriosclerosis, asthenia, body temperature decreased, cerebral atrophy, chest x-ray abnormal, clostridium difficile colitis, diastolic dysfunction, disease progression, emphysema. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, MEGACE, DUONEB, PERCOCET, PROTONIX. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5248432-6
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 06, 2007. Male patient, 72 years of age, weighting 171.7 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, haemoglobin decreased, pneumonia
, respiratory distress, respiratory failure. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with PREDNISONE, LISINOPRIL, ATENOLOL. Patient was hospitalized. Patient died on 01/18/2007.Erlotinib Side Effects Report #5320705-8
Erlotinib side effect was reported by a Physician from UNITED STATES on Apr 17, 2007. Male patient, 72 years of age, weighting 171.7 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, disease progression, lung cancer metastatic, pneumonia
, pulmonary fibrosis . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with PREDNISONE, LISINOPRIL, ATENOLOL. Patient was hospitalized. Patient died on 01/18/2007.Erlotinib Side Effects Report #5374082-7
Erlotinib side effect was reported by a Physician from UNITED STATES on June 12, 2007. Female patient, 72 years of age, weighting 121.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, dysphagia, fatigue, hydropneumothorax, hypoxia, lung neoplasm, mucosal exfoliation, mucosal inflammation, oesophageal stenosis. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with MUPIROCIN CREAM, NORVASC, ENALAPRIL, SYNTHROID, SYSTANE, BENZOCAINE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6009087-6
Erlotinib side effect was reported by a Consumer or non-health professional from FRANCE on Dec 02, 2008. Female patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, dementia
, disease progression, hyperthyroidism. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with DOXYCYCLINE, ALPRAZOLAM, PRAVASTATIN, CALCIPRAT D, PAROXETINE HYDROCHLORIDE, TIMOPTIC, CARBOPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5736884-4
Erlotinib side effect was reported by a Health Professional from JAPAN on Apr 24, 2008. Female patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: autoimmune thrombocytopenia, blood lactate dehydrogenase increased, disease progression, interstitial lung disease, skin disorder. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with RISEDRONIC ACID, MUCOSTA, TRANSAMIN. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5776183-8
Erlotinib side effect was reported by a Physician from JAPAN on May 29, 2008. Female patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, disease progression, interstitial lung disease, metastases to bone, metastases to central nervous system, performance status decreased, skin disorder. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with RISEDRONIC ACID, MUCOSTA, TRANSAMIN. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5721536-7
Erlotinib side effect was reported by a Physician from JAPAN on Apr 11, 2008. Female patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, haemoglobin decreased, non-small cell lung cancer, platelet count decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MOBIC. Patient died on 03/23/2008.
Erlotinib Side Effects Report #6063627-X
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 14, 2009. Male patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activities of daily living impaired, aphonia, cough, diarrhoea, diplopia, disease progression, nausea
, optic ischaemic neuropathy, rash . Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PEMETREXED, DEXAMETHASONE, COMPAZINE, FOLIC ACID. Patient recovered.Erlotinib Side Effects Report #6137700-1
Erlotinib side effect was reported by a Physician from FRANCE on Mar 13, 2009. Male patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, disease progression. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MORPHINE SULPHATE, KETOPROFEN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5902507-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 11, 2008. Male patient, 69 years of age, weighting 183.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression, dyspnoea exertional, haemoptysis, increased upper airway secretion, liver disorder, lung disorder, malaise, nausea
. Erlotinib dosage: (150 MG, QD), ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5067003-8
Erlotinib side effect was reported by a Physician from UNITED STATES on July 12, 2006. Male patient, 68 years of age, weighting 125.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, performance status decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, CARBOPLATIN, PACLITAXEL. Patient died on 07/03/2006.
Erlotinib Side Effects Report #5093284-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Aug 11, 2006. Male patient, 68 years of age, weighting 125.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, disease progression, hyperhidrosis, loss of consciousness, performance status decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient died on 07/03/2006.
Erlotinib Side Effects Report #6032157-3
Erlotinib side effect was reported by a Physician from SWITZERLAND on Dec 23, 2008. Male patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, dysphagia, lymphoedema. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIAUMAB, GEMZAR, CARBOPLATIN, METAMIZOLE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5230795-9
Erlotinib side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Jan 26, 2007. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchiectasis, diabetes mellitus inadequate control, disease progression, necrosis, pleural effusion, pneumonia
, pneumothorax, subcutaneous emphysema, tuberculosis . Erlotinib dosage: 150 MG QD, ORAL. During the same period patient was treated with METFORMIN, GLIMEPIRIDE, MONTELUKAST, TAMSULOSIN, TRIAMCINOLONE, SENNOSIDE, CLARINASE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5245532-1
Erlotinib side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Feb 02, 2007. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchiectasis, bronchoscopy abnormal, disease progression, haemoptysis, lung consolidation, necrosis, pleural effusion, pneumonia
, pneumothorax. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with METFORMIN, GLIMEPIRIDE, MONTELUKAST, TAMSULOSIN, TRIAMCINOLONE, SENNOSIDE, CLARINASE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5500155-1
Erlotinib side effect was reported by a Health Professional from KOREA, REPUBLIC OF on Oct 10, 2007. Male patient, 66 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood calcium decreased, blood glucose increased, blood phosphorus decreased, blood sodium decreased, carbon dioxide decreased, disease progression, interstitial lung disease, lymphocyte percentage decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with RIFAMPICIN, ETHAMBUTOL. Patient died on 07/17/2007.
Erlotinib Side Effects Report #5875385-X
Erlotinib side effect was reported by a Health Professional from IRELAND on Aug 22, 2008. Female patient, 66 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dactylitis, disease progression, palmar-plantar erythrodysaesthesia syndrome. Erlotinib dosage: 150 MG (150 MG, QD), ORAL. During the same period patient was treated with ZOTON, CATAFLAM, LEVOTHYROXINE. Patient died on 04/14/2008.
Erlotinib Side Effects Report #5192758-1
Erlotinib side effect was reported by a Physician from SWITZERLAND on Dec 04, 2006. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, haemoglobin decreased, intestinal ischaemia, malignant pleural effusion, metastases to bone, metastases to liver, pathological fracture, pelvic fracture. Erlotinib dosage: 150 MG, ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #6079735-3
Erlotinib side effect was reported by a Health Professional from SPAIN on Jan 28, 2009. Male patient, 64 years of age, weighting 134.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ataxia
, depression , disease progression, speech disorder. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with VOLTAREN, ENALAPRIL MALEATE, OMEPRAZOLE, MEGESTROL ACETATE, LORAZEPAM, FENTANYL, METFORMIN. Patient was hospitalized. Patient died on 09/08/2008.Erlotinib Side Effects Report #5535090-6
Erlotinib side effect was reported by a Physician from CANADA on Nov 16, 2007. Female patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, diarrhoea, disease progression, hypotension, somnolence. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with PIOGLITAZONE, RABEPRAZOLE, TRAZODONE, LEVOTHYROXINE, PAROXETINE, EPREX, CIPROFLOXACIN, LOPERAMIDE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6003567-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 12, 2008. Male patient, 60 years of age, weighting 176.4 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: convulsion, disease progression. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6025084-9
Erlotinib side effect was reported by a Physician from JAPAN on Dec 17, 2008. Male patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchostenosis, disease progression, interstitial lung disease, mediastinal disorder, metastases to bone, metastases to lung, metastases to lymph nodes, non-small cell lung cancer stage iv, rash
. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with MAXIPIME, CIPROFLOXACIN, MEROPEN, MUCODYNE, MAGLAX, NOVAMIN, NAIXAN. Patient was hospitalized. Patient died on 04/30/2008.Erlotinib Side Effects Report #5749095-3
Erlotinib side effect was reported by a Physician from HUNGARY on Apr 14, 2008. Male patient, 59 years of age, weighting 160.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardiovascular insufficiency, disease progression, hepatic failure, non-small cell lung cancer, respiratory failure. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with SUNITINIB. Patient died on 03/26/2008.
Erlotinib Side Effects Report #5840320-7
Erlotinib side effect was reported by a Health Professional from UNITED STATES on July 28, 2008. Male patient, 59 years of age, weighting 166.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, chest pain
, cough, disease progression, hyperhidrosis, pyrexia, renal cyst, renal failure, rhinorrhoea. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with METOPROLOL TARTRATE, LOPERAMIDE HYDROCHLORIDE, PAREGORIC, VITAMIN B6, IRON. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5711266-X
Erlotinib side effect was reported by a Health Professional from ROMANIA on Apr 01, 2008. Male patient, 58 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, metastases to central nervous system. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with CARBOPLATIN, VINORELBINE TARTRATE. Patient died on 01/02/2008.
Erlotinib Side Effects Report #6058039-9
Erlotinib side effect was reported by a Physician from JAPAN on Jan 16, 2009. Male patient, 58 years of age, weighting 136.7 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, candidiasis, cough, crepitations, diarrhoea, disease progression, dyspnoea, hepatic cancer metastatic. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with FUDOSTEINE, NOVAMIN, FENTANYL, ITRACONAZOLE, CODEINE PHOSPHATE. Patient died on 12/24/2008.
Erlotinib Side Effects Report #6132639-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Mar 09, 2009. Female patient, 57 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchial neoplasm, cough, disease progression, dyspnoea, ejection fraction decreased, excessive granulation tissue, lobar pneumonia, myocardial infarction, obstructive airways disorder. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with DASATINIB, ALBUTEROL, SPIRIVA, METOPROLOL TARTRATE. Patient was hospitalized. Patient died on 02/27/2009.
Erlotinib Side Effects Report #5748667-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 07, 2008. Male patient, 56 years of age, weighting 141.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ataxia
, diplopia, disease progression, haemoglobin decreased, non-small cell lung cancer. Erlotinib dosage: unknown. During the same period patient was treated with ENZASTAURIN, TEGRETOL, KEPPRA, PROZAC, ZYRTEC, VYTORIN, LOTREL, EFFEXOR. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5765433-X
Erlotinib side effect was reported by a Physician from JAPAN on May 23, 2008. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, pneumothorax. Erlotinib dosage: (150 MG,QD),ORAL. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #4628550-3
Erlotinib side effect was reported by a Health Professional from on Feb 28, 2005. Male patient, 53 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: balance disorder, confusional state, disease progression, dysarthria, encephalopathy, fall
, metastases to bone, somnolence. Erlotinib dosage: 150 MG QD, ORAL. During the same period patient was treated with WARFARIN, THIAMIN, VITAMIN B, LANSOPRAZOLE. Patient was hospitalized. Patient died on 03/08/2005.Erlotinib Side Effects Report #5503581-X
Erlotinib side effect was reported by a Health Professional from KOREA, REPUBLIC OF on Oct 12, 2007. Male patient, 52 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: back pain
, condition aggravated, disease progression, metastases to liver. Erlotinib dosage: (150 MG, 1 IN 1 D), ORAL. During the same period patient was treated with MAGNESIUM OXIDE, NEURONTIN, TAGAMET, OXYCONTIN, IR CODONE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5676765-8
Erlotinib side effect was reported by a Physician from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF on Mar 03, 2008. Male patient, 52 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: back pain
, disease progression, metastases to liver, treatment failure. Erlotinib dosage: (150MG,1 IN 1 D), ORAL. During the same period patient was treated with MAGNESIUM OXIDE, NEURONTIN, TAGAMET, OXYCONTIN, IR CODONE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5196407-8
Erlotinib side effect was reported by a Health Professional from SPAIN on Dec 11, 2006. Male patient, 51 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anxiety
, asthenia, band neutrophil count increased, cardiac output decreased, coordination abnormal, disease progression, malaise, mediastinal shift, myalgia. Erlotinib dosage: 150 MG (QD) ORAL. During the same period patient was treated with OMEPRAZOLE, DEXAMTHASONE, ANALGESICS, MORPHINE. Patient was hospitalized and became disabled. Patient recovered.Erlotinib Side Effects Report #5329326-4
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on May 15, 2007. Female patient, 49 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, suicidal ideation. Erlotinib dosage: 150 MG, QD. During the same period patient was treated with FULVESTRANT, LEXAPRO, OXYCODONE, ONDANSETRON, PROCHLORPERAZINE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5331791-3
Erlotinib side effect was reported by a Physician from UNITED STATES on May 02, 2007. Female patient, 49 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, suicidal ideation. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with FASLODEX, GEMCITABINE, CARBOPLATIN, ESCITALOPRAM OXALATE, OXYCODONE, ONDANSETRON, PROCHLORPERAZINE MALEATE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5351043-5
Erlotinib side effect was reported by a Physician from UNITED STATES on May 21, 2007. Female patient, 49 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, suicidal ideation. Erlotinib dosage: 150 MG (QD); ORAL. During the same period patient was treated with FASLODEX, BEVACIZUMAB, GEMCITABINE, CARBOPLATIN, ESCITALOPRAM OXALATE, OXYCODONE, ONDANSETRON, PROCHLORPERAZINE MALEATE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5979000-6
Erlotinib side effect was reported by a Health Professional from CANADA on Nov 14, 2008. Female patient, 42 years of age, weighting 140.4 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, disease progression, lipase increased, red cell distribution width increased. Erlotinib dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6030938-3
Erlotinib side effect was reported by a Health Professional from CANADA on Dec 22, 2008. Female patient, 42 years of age, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, pancreatitis acute. Erlotinib dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5634045-0
Erlotinib side effect was reported by a Physician from BRAZIL on Feb 06, 2008. Female patient, 40 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, nervous system disorder. Erlotinib dosage: (150 MG, QD), ORAL. Patient died on 08/13/2005.
Erlotinib Side Effects Report #5268194-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 14, 2007. Male patient, weighting 154.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, disease progression. Erlotinib dosage: 150MG DAILY PO. During the same period patient was treated with MORPHINE SULPHATE, DILAUDID, COLACE, ZOFRAN, COMPAZINE, TEMAZEPAM, NEXIUM, MEGACE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5309020-6
Erlotinib side effect was reported by a Physician from KOREA, REPUBLIC OF on Apr 05, 2007. Male patient, weighting 123.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood alkaline phosphatase increased, blood chloride decreased, blood cholesterol decreased, blood glucose decreased, blood sodium decreased, bronchial obstruction, disease progression, dyspnoea. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with OXYCODONE, AMITRIPTYLINE. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5103139-0
Erlotinib side effect was reported by a Physician from KOREA, REPUBLIC OF on Aug 23, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: buttock pain, condition aggravated, disease progression, hepatic lesion, mass, pleural disorder
. Erlotinib dosage: unknown. During the same period patient was treated with OXYCODONE, AMITRIPTYLINE. Patient was hospitalized and became disabled. Patient recovered.Erlotinib Side Effects Report #5624289-6
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 08, 2008. Female patient, weighting 111.3 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, malignant pleural effusion. Erlotinib dosage: 150MG ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5652107-9
Erlotinib side effect was reported by a Physician from ITALY on Feb 19, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: agitation, chest pain
, disease progression, dyspnoea, peripheral vascular disorder. Erlotinib dosage: 150 MG, QD, ORAL. Patient died.Erlotinib Side Effects Report #5664281-9
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 27, 2008. Female patient, weighting 100.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, disease progression, large intestine perforation, mental status changes, renal failure, urinary tract infection
. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with BEVACIZUMAB, HEPARIN, LEVOTHYROXINE, PREDNISONE, ATENOLOL, FENTANYL, PERCOCET. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5993069-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Dec 10, 2008. Female patient, weighting 82.89 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest pain
, disease progression, lymphadenopathy, mediastinal disorder. Erlotinib dosage: 150 MG QD PO. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6105608-3
Erlotinib side effect was reported by a Physician from UNITED STATES on Mar 04, 2009. Female patient, weighting 108.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchial neoplasm, bronchial obstruction, disease progression, ejection fraction decreased, myocardial infarction, respiratory failure, upper respiratory tract infection. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB, ALBUTEROL, SPIRIVA, METOPROLOL TARTRATE. Patient was hospitalized. Patient died on 02/27/2009.
Erlotinib Side Effects Report #4906259-6
Erlotinib side effect was reported by a Health Professional from RUSSIAN FEDERATION on Jan 24, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, embolism, non-small cell lung cancer. Erlotinib dosage: 150 MG (QD), ORAL. Patient died.
Erlotinib Side Effects Report #5699456-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 07, 2008. Female patient, weighting 145.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, muscular weakness, myopathy steroid. Erlotinib dosage: 150MG, QD, PO. During the same period patient was treated with RAPAMUNE, PREVACID, DECADRON, NORVASC, LOPRESSOR, DILAUDID, COUMADIN, REMERON. Patient died on 02/02/2007.
Erlotinib Side Effects Report #5736921-7
Erlotinib side effect was reported by a Physician from ARGENTINA on Apr 25, 2008. Male patient, 60 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, pleural effusion. Erlotinib dosage: (150 MG), ORAL. During the same period patient was treated with MAGNESIUM. Patient died.
Erlotinib Side Effects Report #6075600-6
Erlotinib side effect was reported by a Health Professional from FRANCE on Jan 27, 2009. Male patient, 53 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: arrhythmia
, cerebrovascular accident, coma, disease progression, electrocardiogram abnormal, pleural effusion, respiratory rate increased. Erlotinib dosage: (150 MG, QD), ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6094382-5
Erlotinib side effect was reported by a Health Professional from FRANCE on Feb 09, 2009. Male patient, 53 years of age, was diagnosed with lung neoplasm malignant, non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cerebrovascular accident, coma, disease progression, malignant neoplasm progression, pleural effusion. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with DOXYCYCLINE. Patient was hospitalized. Patient died on 01/21/2009.
Erlotinib Side Effects Report #4953979-3
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 23, 2006. Female patient, 50 years of age, weighting 141.1 lb, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression. Erlotinib dosage: 150 MG. During the same period patient was treated with OXYCONTIN, OXYCODON, COLACE, LORAZEPAM. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6124013-7
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 18, 2009. Female patient, weighting 108.5 lb, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression. Erlotinib dosage: 150 MG DAILY PO. During the same period patient was treated with SUNITINIB. Patient died.
Erlotinib Side Effects Report #5232502-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 06, 2007. Female patient, weighting 119.0 lb, was diagnosed with lung cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, disease progression, metastases to bone. Erlotinib dosage: 150 MG DAILY ORAL. During the same period patient was treated with BEVACIZUMAB. Patient died on 02/04/2007.
Erlotinib Side Effects Report #5748796-0
Erlotinib side effect was reported by a Physician from JAPAN on May 06, 2008. Female patient, 78 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, cachexia, condition aggravated, disease complication, disease progression, eating disorder
, gastroduodenal ulcer, gastrointestinal oedema. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BETAMETHASONE, FAMOTIDINE, DEPAS. Patient died on 04/21/2008.Erlotinib Side Effects Report #5676878-0
Erlotinib side effect was reported by a Physician from JAPAN on Mar 04, 2008. Male patient, 75 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, hypoxia. Erlotinib dosage: 150 MG QD ORAL. During the same period patient was treated with DECADRON, POLYFUL, EURODIN, FAMOTIDINE, DOMPERIDONE, GASMOTIN, MAGNESIUM OXIDE. Patient recovered.
Erlotinib Side Effects Report #6099808-9
Erlotinib side effect was reported by a Physician from JAPAN on Feb 13, 2009. Female patient, 75 years of age, weighting 143.3 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, arterial thrombosis limb, diarrhoea, disease progression, nausea
, rash . Erlotinib dosage: (150 MG, QD), ORAL; (150 MG, QD), ORAL. During the same period patient was treated with VITAMEDIN, METHYCOBAL, PRAVASTATIN, LOXONIN, SELBEX, NAUZELIN. Patient recovered.Erlotinib Side Effects Report #5956029-5
Erlotinib side effect was reported by a Physician from JAPAN on Oct 27, 2008. Male patient, 72 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression, faecal incontinence, paronychia, quality of life decreased. Erlotinib dosage: (150 MG. QD), ORAL. During the same period patient was treated with JUVELA NICOTINATE, BIOFERMIN, LOXONIN, MUCOSTA, MORPHINE, MYSLEE, HARNAL, EVIPROSTAT. Patient recovered.
Erlotinib Side Effects Report #6081650-6
Erlotinib side effect was reported by a Health Professional from JAPAN on Jan 30, 2009. Male patient, 71 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cell marker increased, disease progression, non-small cell lung cancer stage iv, rash pustular. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with DIOVAN, MOBIC, ROHYPNOL, LENDORM. Patient recovered.
Erlotinib Side Effects Report #5891573-0
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 04, 2008. Male patient, 70 years of age, weighting 120.4 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: adenocarcinoma, aortic valve incompetence, blood pressure decreased, cardiac tamponade, cholecystitis, depressed level of consciousness, disease progression, hepatic function abnormal, interstitial lung disease. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with TAZOCIN, LANSOPRAZOLE, CODEINE PHOSPHATE, CYTOTEC, ETODOLAC, DUROTEP, FAMOTIDINE, CEFMATAZOLE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5788681-1
Erlotinib side effect was reported by a Physician from JAPAN on June 09, 2008. Male patient, 69 years of age, was diagnosed with lung adenocarcinoma, pyrexia and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: c-reactive protein increased, disease progression, dyspnoea, pruritus, pyrexia, rash
, rhinorrhoea. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with FINIBAX, ADALAT, MUCODYNE, HOKUNALIN, THEOLONG, PREDONINE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5818453-0
Erlotinib side effect was reported by a Physician from JAPAN on July 03, 2008. Male patient, 69 years of age, was diagnosed with lung adenocarcinoma, pyrexia and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: c-reactive protein increased, disease progression, dyspnoea, pruritus, pyrexia, rash
, rhinorrhoea. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with FINIBAX, ADALAT, MUCODYNE, HOKUNALIN, THEOLONG, PREDONINE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5832824-8
Erlotinib side effect was reported by a Health Professional from JAPAN on July 18, 2008. Female patient, 68 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, diarrhoea, disease progression, enterocolitis infectious, epilepsy
, fatigue. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with ONEALFA, PHENYTOIN, THRYADIN. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5979444-2
Erlotinib side effect was reported by a Physician from JAPAN on Nov 13, 2008. Male patient, 68 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, infection
, left ventricular dysfunction, pyrexia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with AMLODIPINE BESYLATE, MICARDIS, HARNAL, BASEN, GLUFAST, NOVOLIN N, GASMOTIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5828484-2
Erlotinib side effect was reported by a Physician from JAPAN on July 14, 2008. Female patient, 67 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cheilitis, disease progression, skin ulcer. Erlotinib dosage: 150 MG QD ORAL. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5844649-8
Erlotinib side effect was reported by a Physician from JAPAN on Aug 01, 2008. Male patient, 66 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: back pain
, disease progression, intestinal obstruction, lumbar spinal stenosis, metastases to bone, metastases to central nervous system. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with METHYCOBAL, GASTER D, MAGMITT, RHYTHMY, DIAZEPAM, AMITRIPTYLINE, KOLANTYL, LOXONIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5844659-0
Erlotinib side effect was reported by a Physician from JAPAN on Aug 01, 2008. Male patient, 66 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression, pulmonary embolism
. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with RABEPRAZOLE, GABAPEN, ASPIRIN, WARFARIN. Patient recovered.Erlotinib Side Effects Report #5917589-3
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 24, 2008. Male patient, 65 years of age, weighting 121.5 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: condition aggravated, dehydration, delirium, disease progression, pneumonia bacterial, pyrexia, renal impairment. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with NOVAMIN, LOXONIN, FAMOTIDINE, MUCODYNE, OXYCONTIN, MAGMITT, PRIMPERAN, CLONAZEPAM. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6088069-2
Erlotinib side effect was reported by a Physician from JAPAN on Feb 06, 2009. Female patient, 64 years of age, weighting 121.3 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, disease progression, gastritis, haemorrhage, haemothorax, rash
, urinary tract infection . Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with GASTER D, TOCOPHEROL CONCENTRATE CAP, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5935299-3
Erlotinib side effect was reported by a Physician from JAPAN on Oct 13, 2008. Male patient, 62 years of age, weighting 138.1 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: delirium, depression
, diarrhoea, disease progression, hepatic function abnormal, interstitial lung disease, lung adenocarcinoma, rash , restlessness. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MYSLEE, DEPAKENE, GASMOTIN, METHYCOBAL, CYTOTEC, OXYCONTIN, NAIXAN, GASTROM. Patient died.Erlotinib Side Effects Report #5679721-9
Erlotinib side effect was reported by a Health Professional from JAPAN on Mar 05, 2008. Female patient, 61 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, disease progression, hypercreatininaemia, hypoxia, viral infection
. Erlotinib dosage: (150 MG, QD), ORAL. Patient recovered.Erlotinib Side Effects Report #5822454-6
Erlotinib side effect was reported by a Physician from JAPAN on July 08, 2008. Female patient, 61 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, disease progression, metastases to liver. Erlotinib dosage: 150 MG QD ORAL. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, TAXOTERE, GEMZAR, CISPLATIN, NAVELBINE, BETAMETHASONE. Patient recovered.
Erlotinib Side Effects Report #5836127-7
Erlotinib side effect was reported by a Physician from JAPAN on July 21, 2008. Female patient, 61 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, disease progression, hypercreatininaemia, hypoxia, viral infection
. Erlotinib dosage: 150 MG, QD; ORAL. During the same period patient was treated with OXYCONTIN. Patient recovered.